tuftsin has been researched along with Experimental Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greenbaum, LM; Narayan, TK; Sutherland, JH | 1 |
| Amoscato, AA; Babcock, GF; Banks, RA; Nishioka, K; Phillips, JH | 1 |
| Bruley-Rosset, M; Hercend, T; Mathé, G; Rappaport, H | 1 |
| Bar-Shavit, Z; Bursuker, I; Goldman, R | 1 |
| Najjar, VA | 1 |
| Bruley-Rosset, M; Florentin, I; Goutner, A; Mathé, G; Serrou, B | 1 |
| Greenbaum, LM | 1 |
| Floc'h, F; Jollès, P; Migliore-Samour, D; Werner, GH | 1 |
1 review(s) available for tuftsin and Experimental Neoplasms
| Article | Year |
|---|---|
Immunomodulating peptides.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antibody Formation; Bacterial Infections; Bacterial Proteins; beta 2-Microglobulin; Chemical Phenomena; Chemistry; Colostrum; Cyclosporins; Fibrinogen; Fungal Proteins; Glycopeptides; Humans; Immunity; Immunity, Cellular; Leucine; Lipoproteins; Macrophages; Milk Proteins; Neoplasms, Experimental; Nerve Tissue Proteins; Peptide Fragments; Peptides; Structure-Activity Relationship; T-Lymphocytes; Thymus Hormones; Tuftsin | 1986 |
7 other study(ies) available for tuftsin and Experimental Neoplasms
| Article | Year |
|---|---|
Pepstatin inhibition of cathepsin D in situ and its modification of leukokinin formation: HPLC separation of fluorescamine-treated kinins.
Topics: Animals; Cathepsin D; Cathepsins; Chromatography, High Pressure Liquid; Fluorescamine; gamma-Globulins; Kinins; Mice; Mice, Inbred DBA; Neoplasms, Experimental; Oligopeptides; Pepstatins; Tuftsin | 1983 |
In vivo and in vitro antitumor activities of tuftsin.
Topics: Animals; Cell Line; Cytotoxicity, Immunologic; Female; Granulocytes; Killer Cells, Natural; Leukemia, Experimental; Macrophages; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Sarcoma, Avian; Tuftsin | 1983 |
Immunorestorative capacity of tuftsin after long-term administration to aging mice.
Topics: Aging; Animals; Antibody-Dependent Cell Cytotoxicity; Female; Immunity; Killer Cells, Natural; Macrophages; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Spleen; T-Lymphocytes, Cytotoxic; Tuftsin | 1983 |
Functional tuftsin binding sites on macrophage-like tumor line P388D1 and on bone marrow cells differentiated in vitro into mononuclear phagocytes.
Topics: Animals; Binding Sites; Bone Marrow Cells; Cell Differentiation; Cell Line; Cells, Cultured; Immunoglobulin Fragments; Macrophages; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Phagocytosis; Tuftsin | 1980 |
Biochemical aspects of tuftsin deficiency syndrome.
Topics: Animals; Bacteria; Humans; Immunoglobulin Fragments; Immunologic Deficiency Syndromes; Macrophage Activation; Macrophages; Mice; Neoplasms, Experimental; Phagocytosis; Tuftsin | 1981 |
Three new agents for immunotherapy trials: azimexon, bestatin, and tuftsin.
Topics: Adjuvants, Immunologic; Animals; Aziridines; Azirines; Cytotoxicity, Immunologic; Drug Evaluation, Preclinical; Immunoglobulin Fragments; Immunotherapy; Leucine; Mice; Neoplasms, Experimental; T-Lymphocytes; Tuftsin | 1982 |
Pepstatin, an inhibitor of acid kininogenases and ascites retardant in neoplastic disease.
Topics: Animals; Ascites; Cathepsins; gamma-Globulins; Mice; Neoplasms, Experimental; Oligopeptides; Pepstatins; Tuftsin | 1979 |